CAR-T Cell Therapy – Frederick Locke, MD, and Robert Figlin, MD, discuss clinical highlights from ASH 2018 - a podcast by OBR Peer-Spectives
from 2018-12-18T21:42:58
::
::
Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Frederick Locke, MD, Program Co-Leader, Immunology, Moffitt Cancer Center discuss CAR-T clinical highlights from ASH 2018
Further episodes of OBR Peer-Spectives
Further podcasts by OBR Peer-Spectives
Website of OBR Peer-Spectives